deltatrials
Completed PHASE2 NCT00002524

Combination Chemotherapy in Treating Patients With AIDS-Related Lymphoma

Pilot Study in AIDS-Related Lymphomas

Sponsor: M.D. Anderson Cancer Center

Conditions Lymphoma
Interventions Bleomycin Sulfate Cisplatin Cyclophosphamide Cytarabine Doxorubicin Hydrochloride (DOX) Etoposide Filgrastim Fluorouracil Ifosfamide Leucovorin calcium Methotrexate Methylprednisolone Pentamidine Prednisone Radiation Therapy Trimethoprim-Sulfamethoxazole Vincristine Sulfate Zidovudine (AZT)
Updated 5 times since 2017 Last updated: Jul 27, 2012 Started: Jun 30, 1993 Primary completion: Oct 31, 2005 Completion: Oct 31, 2005

A PHASE2 clinical study on Lymphoma, this trial is completed. The trial is conducted by M.D. Anderson Cancer Center and has accumulated 5 data snapshots since 1993. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 19 months · monthly snapshotCompleted

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE2

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE2

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE2

    First recorded

Jun 1993

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • M.D. Anderson Cancer Center
  • National Cancer Institute (NCI)
Data source: M.D. Anderson Cancer Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations